Financials

  • Market Capitalization 956.84 M
  • Employee 108
  • Founded 2017
  • CEO N/A
  • Website www.januxrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZHSKH11
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.55
Rapporto prezzo/fatturato
62.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2486
ANRO
Alto Neuroscience, Inc. Common Stock
27.04 USD-2.87%+0.67%+24.72%+944.02%948.94 M USD
2493
AVTX
Avalo Therapeutics, Inc. - Common Stock
18.46 USD+0.22%-6.91%+26.53%+280.62%970.36 M USD
2512
SLDB
Solid Biosciences Inc. - Common Stock
9.46 USD-1.77%-15.99%+29.59%+65.96%931.33 M USD
2518
DBVT
DBV Technologies S.A. - American Depositary Shares
15.50 USD-2.64%-9.30%-15.35%+60.12%917.73 M USD

Notizie